Thrombolex, Inc., a developer of treatments for arterial and venous thromboembolic diseases, announced the publication of the resu ...

Penumbra's AI-guided aspiration system and scalable platform uniquely position it as a leader in stroke and PE intervention.

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Pulmonary embolism (PE) remains one of the leading causes of maternal mortality. At the French Thoracic Society Spring Days ...

Background Several factors have been associated with mortality in the months after PE. Factors associated with short-term clinical deterioration or need for hospital-based intervention are less well ...